AI
| Followers | 473 |
| Posts | 24013 |
| Boards Moderated | 0 |
| Alias Born | 02/05/2004 |
Tuesday, February 10, 2015 9:37:17 PM
1:20 - "Begining with our Lympro assay, right now we are in final discussions around our first customer base for that asset."
4:48 - "We have already launched our Lymprotest for the Investigaton Use Market and are in active business development discussions with many Pharmas and expect to have a first customer shortly."
Just a couple of months ago Gerald gave us LymPro revenue guidance and said the RUO market for LymPro in FY15 was $150-Mil., of which LymPro would get a "significant portion." In early November however, Jason Napodano said Lympro revenue in FY15 would be $1-Mil. and $3.5-Mil. in FY16
Just who is telling the truth - Gerald or Jason
its quite obvious, when you look at credibility...
4:48 - "We have already launched our Lymprotest for the Investigaton Use Market and are in active business development discussions with many Pharmas and expect to have a first customer shortly."
Just a couple of months ago Gerald gave us LymPro revenue guidance and said the RUO market for LymPro in FY15 was $150-Mil., of which LymPro would get a "significant portion." In early November however, Jason Napodano said Lympro revenue in FY15 would be $1-Mil. and $3.5-Mil. in FY16
Just who is telling the truth - Gerald or Jason
its quite obvious, when you look at credibility...
